111 related articles for article (PubMed ID: 7062137)
1. Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication.
Echenique RL; Kasi L; Haynie TP; Glenn HJ; Samaan NA; Hill CS
J Nucl Med; 1982 Mar; 23(3):235-40. PubMed ID: 7062137
[TBL] [Abstract][Full Text] [Related]
2. Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well-differentiated thyroid cancer.
Aiello DP; Manni A
Arch Intern Med; 1990 Feb; 150(2):437-9. PubMed ID: 2105703
[TBL] [Abstract][Full Text] [Related]
3. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin levels to follow-up patients with treated differentiated thyroid carcinoma.
Moser E; Braun S; Büell U; Kirsch CM; Tosch U; Wendt T
Cancer Detect Prev; 1984; 7(2):79-86. PubMed ID: 6424939
[TBL] [Abstract][Full Text] [Related]
5. 131I total body scan and serum thyroglobulin assay in the follow-up of surgically treated patients affected by differentiated thyroid carcinoma.
Panza N; Lombardi G; Minozzi M; Salvatore M; Claudio F; Mariano A; Macchia V
J Nucl Med Allied Sci; 1984; 28(1):9-12. PubMed ID: 6481470
[No Abstract] [Full Text] [Related]
6. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
Herle AJ; Uller RP
J Clin Invest; 1975 Aug; 56(2):272-7. PubMed ID: 1150869
[TBL] [Abstract][Full Text] [Related]
8. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
9. [Follow-up care for differentiated thyroid cancer].
Hüfner M; Reiners C
Dtsch Med Wochenschr; 1986 Nov; 111(45):1732-4. PubMed ID: 3536387
[No Abstract] [Full Text] [Related]
10. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
[TBL] [Abstract][Full Text] [Related]
12. [The thyroglobulin level in blood: a reliable indicator of metastasis in the follow-up study of patients with functioning thyroid carcinoma].
Sluiter WJ; Sijperda A; Piers DA; Reitsma WD; Fleuren GJ; Oosterhuis JW; Vermey A; Doorenbos H
Ned Tijdschr Geneeskd; 1983 Jun; 127(26):1133-8. PubMed ID: 6888573
[No Abstract] [Full Text] [Related]
13. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
14. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
Kim SJ; Lee TH; Kim IJ; Kim YK
Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
[TBL] [Abstract][Full Text] [Related]
15. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
16. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.
Frasoldati A; Pesenti M; Gallo M; Caroggio A; Salvo D; Valcavi R
Cancer; 2003 Jan; 97(1):90-6. PubMed ID: 12491509
[TBL] [Abstract][Full Text] [Related]
18. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
Weightman DR; Mallick UK; Fenwick JD; Perros P
Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
[TBL] [Abstract][Full Text] [Related]
19. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
[TBL] [Abstract][Full Text] [Related]
20. Thyroglobulin measurements in the follow-up of patients with differentiated thyroid carcinoma: comparison with quantitative radioactive iodine uptake measurements and total body scans.
Bolk JH; Bussemaker JK; Nieuwenhuijzen Kruseman AC; De Vijlder JJ; Goslings BM
Neth J Med; 1985; 28(9):340-6. PubMed ID: 4047268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
